Moody Aldrich Partners »

Amylyx Pharmaceuticals shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 58k 17.96
2022-12-31 $1.4M 38k 36.95

More positions owned by Moody Aldrich Partners

Element Solutions (ESI)
Oruka Therapeutics (ORKA)
Independent Bank (INDB)
Wintrust Financial Corporation (WTFC)
Ligand Pharmaceuticals Com New (LGND)
Old National Ban (ONB)
Columbia Banking System (COLB)
Riot Blockchain (RIOT)
Meta Financial (CASH)
Core Scientific (CORZ)
Protagonist Therapeutics (PTGX)
Dianthus Therapeutics (DNTH)
Cipher Mining (CIFR)
Ambiq Micro Common Stock (AMBQ)
Hut 8 Corp (HUT)

View all positions for Moody Aldrich Partners

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Commodore Capital
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
Adage Capital Partners GP
First Light Asset Management
Driehaus Capital Management
Goldman Sachs Group
State Street Corporation
Franklin Resources
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals